期刊文献+

多级超滤及亲和超滤法分离纯化NADH工艺的研究

Study on the Isolation and Purification of NADH by Multi-ultrafiltration and Affinity Ultrafiltration
下载PDF
导出
摘要 研究出一种经济、高效、简便且容易放大的提取、分离和纯化辅酶NADH的工艺条件并进行优化。使用化学渗透法处理啤酒酵母细胞Saccharomyces cerevisiae粗提NADH,多级超滤及亲和超滤法进一步分离和纯化NADH。选用酵母醇脱氢酶(YADH)作为亲和配体,在pH值8.0,离子强度为0.1 mol/L时,用YADH和细胞渗透液中的NADH亲和。使用MWCO=30 000的滤膜超滤。结果:NADH-YADH复合物留在截留液中,从而与其它小分子物质分离。改变pH值和离子强度,NADH-YADH复合物解离,通过MWCO=1 000的滤膜超滤,NADH分离到滤过液中,YADH作为截留而回收,回收率达93%,活性损失15%。试验表明使用化学渗透法处理酵母细胞,用亲和超滤纯化可获得高的NADH产率。和以前的方法相比具有简单、经济、省时、高效等特点,且容易放大。 The purpose is to find and optimize a technique which is simple, inexpensive and high-yield, for isolation and purification of NADH. Saccharomyces cerevisiae cells were treated by chemical permeabilization to release NADH. Isolation and purification of NADH were conducled by multi-ultrafiltration and affinity ultrafiltration. The NADH was separated by binding to YADH at pH 8. 0, and with ionic strength 0. 1 mol/L. The NADH-YADH complex was separated from other molecules by ultrafiltration using membrane of which the molecular weight cut-off (MWCO) was 30000 and the binary complex was retained. The NADH-YADH complex was cleaved by changing pH and ionic strength. Ultrafiltration (MWCO=1000)was carried out then to isolate NADH as ultrafiltrate. YADH was recovered as ultraretention with 95 % recovery and 15 % loss in activity. It was found that treating Saccharomyces cerevisiae cells by chemical permeabilization and purification by affinity ultrafiltration gives NADH with high yields. The technique is simple, inexpensive, and less time-consuming. It's easier to be scaled up than other methods, too.
出处 《药物生物技术》 CAS CSCD 2005年第5期317-322,共6页 Pharmaceutical Biotechnology
基金 全军"十五"卫生科研基金(No.01MA138)
关键词 还原型烟酰胺腺嘌呤二核苷酸 膜分离技术 亲和超滤 Nicotinamide adenine dinucleotide reduced (NADH), Membrane separation technologies,Affinity ultrafiltration
  • 相关文献

参考文献23

  • 1Birkmayer-GD. NADH - The energizing coenzyme[M].New Canaan: Keats, 1998,1
  • 2Brambilla L, Stili P, Guidarelli A, et al. Electron transportmediated wasteful consumption of NADH promotes the lethal response of U937 cells to Tert-Butydroperoxide[J]. J Pham Exp Therap,1998,284: 1112.
  • 3Birkmayer-GD, Vrecko K, Volc D, et al. Nicotinamide ademine dinucleotide(NADH)-a new therapeutic approach to Parkinson's disease, comparison of oral and parenteral appli cation[J]. Acta Neurol Scand, 1993,87: 32.
  • 4Roderick K. NADH shows promise in study, FDA trial a first for nutritional supplements[J]. CFEIDS Chronicle,1998,11: 25.
  • 5Zhang JR, Vreck K, Nadlinger K, Reibnegger G. NADH (reduced coenzyme Ⅰ) rescue PC12 cells from apoptosis induced by cispatin[J]. J Tumor Marker Oncology, 1998,13(3): 11.
  • 6Liu FQ, Zhang JR. L02 cells from X-ray induced damage rescued by new anti-oxidant NADH[J]. World J Gastroenterol, 2003,9(8): 1781.
  • 7张积仁,温居一,徐萌,Georg Birkmayer.还原型辅酶Ⅰ(NADH)对PC12细胞鱼藤酮损伤的分子调控[J].解放军医学杂志,2002,27(3):192-193. 被引量:6
  • 8Slade N, Storga-Tomjic D, Birkmayer GD, et al. Effect of extra-cellular NADH on human tumor cell proliferation[J].Anticancer Res, 1999,19: 5355.
  • 9Torabi F, Ramanthan K, Larsson PO, et al. Coulometric determination of NAD and NADH in normal and cancer cells using LDH, RVC and a polymer mediator[ J]. Talanta,1999,50: 787.
  • 10Dunnill P. Trends in downstream processing of proteins and enzymes. Process Biochemistry[J]. 1983,18(5),9.

二级参考文献7

  • 1[1]Zhang JR, Vreck K, Nadlinger K et al. NADH (reduced coenzyme I) rescues PC12 cells from apoptosis induced by cisplatin. J Tumor Mark Oncol, 1998, 13(3): 11
  • 2[2]Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65(1-2):55
  • 3[3]Stecca C, Gerber GB. Adaptive response to NDA-damaging agents: a review of potential mechanisms. Biochem Pharmacol, 1998, 55(7): 941
  • 4[4]Macaya A. Apoptosis in the nervous system. Rev Neurol, 1996, 24(135):1356
  • 5[5]Lovschall H, Kassem M, Mosekilde L. Apoptosis: molecular aspects. Nord Med, 1997, 112(8):271
  • 6[6]Blagosklonny MV, Ei-Deiry WS. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cell. Int J Cancer, 1998, 75(6):933
  • 7[7]Da-Gong W, Colin FJ, John JM et al. Expression of the apoptosis-suppressing gene bcl-2 in pheochromocytoma is associated with the expression of c-myc. J Clin Endocrinol Metab, 1997, 82 (6):1949

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部